CINECA IRIS Institutional Research Information System

WILLIAMS, Tracy Ann
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.323
AS - Asia 5.091
EU - Europa 4.966
SA - Sud America 1.140
OC - Oceania 222
AF - Africa 143
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.559
CN - Cina 2.672
IT - Italia 1.012
DE - Germania 821
JP - Giappone 730
MX - Messico 513
BR - Brasile 424
FR - Francia 369
ES - Italia 368
IE - Irlanda 352
GB - Regno Unito 267
CO - Colombia 264
TR - Turchia 251
SG - Singapore 237
SE - Svezia 219
AU - Australia 212
CA - Canada 201
AT - Austria 190
IN - India 171
PL - Polonia 169
HK - Hong Kong 165
TW - Taiwan 163
FI - Finlandia 162
AR - Argentina 161
VN - Vietnam 152
KR - Corea 143
CL - Cile 122
NL - Olanda 120
CH - Svizzera 111
GR - Grecia 109
TH - Thailandia 105
UA - Ucraina 105
PT - Portogallo 87
BE - Belgio 86
RU - Federazione Russa 84
PE - Perù 72
RO - Romania 68
EC - Ecuador 56
MY - Malesia 49
CZ - Repubblica Ceca 48
ID - Indonesia 40
DZ - Algeria 32
SA - Arabia Saudita 30
IL - Israele 29
DK - Danimarca 28
HU - Ungheria 25
BG - Bulgaria 22
HR - Croazia 22
IR - Iran 22
NO - Norvegia 22
AE - Emirati Arabi Uniti 20
ZA - Sudafrica 20
BA - Bosnia-Erzegovina 19
RS - Serbia 19
TN - Tunisia 19
MA - Marocco 18
JO - Giordania 16
LT - Lituania 15
PH - Filippine 15
VE - Venezuela 15
DO - Repubblica Dominicana 12
IQ - Iraq 11
UY - Uruguay 11
NZ - Nuova Zelanda 10
SK - Slovacchia (Repubblica Slovacca) 10
EG - Egitto 8
OM - Oman 8
SI - Slovenia 8
BY - Bielorussia 7
CR - Costa Rica 7
KE - Kenya 7
KW - Kuwait 7
LB - Libano 7
MT - Malta 7
PA - Panama 7
PY - Paraguay 7
QA - Qatar 7
SV - El Salvador 7
BO - Bolivia 6
HN - Honduras 6
SN - Senegal 6
CM - Camerun 5
IS - Islanda 5
KZ - Kazakistan 5
NG - Nigeria 5
UG - Uganda 5
GE - Georgia 4
KH - Cambogia 4
NI - Nicaragua 4
NP - Nepal 4
PK - Pakistan 4
SY - Repubblica araba siriana 4
BN - Brunei Darussalam 3
EU - Europa 3
LV - Lettonia 3
MK - Macedonia 3
MM - Myanmar 3
PR - Porto Rico 3
ZM - Zambia 3
AZ - Azerbaigian 2
Totale 16.855
Salva come PNG Salva come JPEG
Città #
Beijing 506
Chandler 394
Fairfield 346
Dublin 327
Houston 273
Wilmington 248
Torino 240
Ashburn 211
Redwood City 207
Shanghai 201
Munich 196
Ann Arbor 195
Vienna 168
Seattle 164
Woodbridge 164
Tokyo 161
Singapore 145
Cambridge 140
Chongqing 122
Medford 115
Bogotá 109
Warsaw 101
Guangzhou 99
Buenos Aires 98
Villeurbanne 95
Princeton 92
Mexico City 89
Chengdu 87
Madrid 84
Turin 82
Santiago 81
São Paulo 78
Taipei 78
Dong Ket 77
Istanbul 75
Pisa 71
Nanjing 70
Nyköping 70
Changsha 68
Milan 64
Jacksonville 61
Hangzhou 57
Lima 57
Barcelona 55
New York 55
Dearborn 53
Wuhan 51
Ankara 48
Central 46
Sydney 46
Paris 45
Bangkok 44
Athens 43
Berlin 42
London 41
Medellín 40
Rome 39
Bologna 38
Zhengzhou 38
Tianjin 36
Boston 35
Fremont 35
Norwalk 35
Guadalajara 34
Padova 34
Rio de Janeiro 33
San Diego 33
Hebei 32
Melbourne 32
Monterrey 32
Montreal 32
Shenzhen 31
Falls Church 30
Rochester 30
Brisbane 29
Moscow 29
Quito 29
Santiago de Cali 29
Würzburg 29
Chicago 28
Los Angeles 28
Perth 28
Valencia 28
Dresden 27
Düsseldorf 27
Helsinki 27
Zurich 27
Bucharest 26
Kuala Lumpur 26
Prague 26
Mumbai 25
Salvador 25
Shenyang 25
Belo Horizonte 24
Ho Chi Minh City 24
Porto 23
Porto Alegre 22
Seoul 22
Hong Kong 21
Izmir 21
Totale 8.259
Salva come PNG Salva come JPEG
Nome #
Diagnosis and treatment of primary aldosteronism 6.313
Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in pr imar y aldosteronism 676
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice 615
Guidelines for primary aldosteronism: uptake by primary care physicians in Europe 582
The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism 515
Mass spectrometry-based adrenal venous steroid profiling for subtyping primary aldosteronism 397
Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism 324
Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas 314
Prediction of hyperaldosteronism subtypes when adrenal vein sampling is unilaterally successful 312
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. 308
Subtype Diagnosis of Primary Aldosteronism: Approach to Different Clinical Scenarios 296
Primary aldosteronism in the elderly 276
Coexisting prolactinoma and primary aldosteronism: Is there a pathophysiological link? 275
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma 266
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism 216
Is there a role for genomics in the management of hypertension? 214
Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary? 197
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas 187
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro 175
Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism 146
KCNJ5 mutations are the most frequent genetic alteration in primary aldosteronism 139
A Novel Y152C KCNJ5 Mutation Responsible for Familial Hyperaldosteronism Type III 132
Aldosterone does not modify gene expression in human endothelial cells 130
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer 130
Classification of microadenomas in patients with primary aldosteronism by steroid profiling 126
Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism 124
Familial hyperaldosteronism type III 116
Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit 116
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions 114
Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism 111
Disordered CYP11B2 Expression in Primary Aldosteronism 111
Assessing outcomes after adrenalectomy for unilateral primary aldosteronism 107
Is Primary Aldosteronism Still Largely Unrecognized? 103
Genetic and Potential Autoimmune Triggers of Primary Aldosteronism 101
Comparative genomics and transcriptome profiling in primary aldosteronism 99
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge kir3.4 residue. 97
Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism 93
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis 90
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms 84
Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells 83
18-Oxocortisol and 18-hydroxycortisol: Is there clinical utility of these steroids? 77
Steroid Hormone Production in Patients with Aldosterone Producing Adenomas 75
The Adrenal Gland: Central Relay in Health and Disease 75
Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure 74
Steroid profiling as an additional tool to confirm one-sided hormone overproduction in primary aldosteronism: A case report 70
In situ metabolomics of aldosterone-producing adenomas 69
Mouse models of primary aldosteronism: From physiology to pathophysiology 69
Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism 67
Visinin-Like 1 Is Upregulated in Aldosterone-Producing Adenomas With KCNJ5 Mutations and Protects From Calcium-Induced Apoptosis. 64
Effect of Dietary Sodium Modulation on Pig Adrenal Steroidogenesis and Transcriptome Profiles 64
Conceptual basis and methodology of the SOPHIA study 63
Role of KCNJ5 in familial and sporadic primary aldosteronism. 62
Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). 62
Diagnosis and management of primary aldosteronism: The endocrine society guideline 2016 revisited 60
Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT) 60
Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification 57
Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism 57
Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas 55
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism 55
Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension 52
Characterization of Circulating Extracellular Vesicle Surface Antigens in Patients With Primary Aldosteronism 49
Clinical Score and Machine Learning-Based Model to Predict Diagnosis of Primary Aldosteronism in Arterial Hypertension 49
Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth 48
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism 47
International histopathology consensus for unilateral primary aldosteronism 47
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability 46
Familial hyperaldosteronism type III 46
Primary aldosteronism: Metabolic reprogramming and the pathogenesis of aldosterone-producing adenomas 44
BEX1 Is Differentially Expressed in Aldosterone-Producing Adenomas and Protects Human Adrenocortical Cells from Ferroptosis 44
Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations 43
KCNJ5 Mutations: Sex, Salt and Selection 42
KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism 41
Renin and aldosterone measurements in the management of arterial hypertension 38
Familial Hyperaldosteronism Type I 37
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 36
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. 35
Progress in Primary Aldosteronism 2019: New Players on the Block? 35
Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients 34
Is familial hyperaldosteronism underdiagnosed in hypertensive children? 33
Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status 31
Part I: Adrenal HypertensionChapter 1:Primary aldosteronism: Progress in Diagnosis, Therapy, and Genetics. 30
Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake 27
Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: The SOPHIA study 25
Timeline of Advances in Genetics of Primary Aldosteronism 25
Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism 23
Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension 19
Translational Control of Aldosterone Production in Aldosterone-Producing Adenomas 16
Diagnosis and Treatment of Primary Aldosteronism in 2017: Did We Achieve Our Goals? 16
Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism—a Review 16
Visualizing adrenal steroids in primary aldosteronism the expected and the unexplained 14
Recent Developments in Primary Aldosteronism 13
Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism 12
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study 9
Whole blood methylome-derived features to discriminate endocrine hypertension 7
Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation 6
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas 5
Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy 5
Totale 17.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.125
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.381 0 45 71 118 106 278 111 137 155 108 105 147
2020/20211.668 99 149 143 87 160 136 115 82 116 201 151 229
2021/20221.822 134 220 101 153 161 123 108 92 110 144 179 297
2022/20233.747 176 131 133 339 286 500 348 314 335 283 418 484
2023/20245.555 515 530 474 463 476 484 416 452 157 511 619 458
2024/2025716 480 236 0 0 0 0 0 0 0 0 0 0
Totale 17.190